1. Pink Sheet

Tech Transfer Deals See Argentina And Serbia Produce COVID Vaccine

 
• By Francesca Bruce

The Russian Direct Investment Fund says it has 20 technology transfer and production agreements in place in 13 countries across the world.

Sputnik Vaccine
Production Of Sputnik Vaccine In Argentina And Serbia Underway • Source: Alamy

Production of the Russian Sputnik V vaccine is now under way in Argentina and Serbia following the signing of technology transfer and production agreements. Similar deals are in place in 11 other countries, according to the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, which is financing the development of the vaccine.

Production in both countries began on 4 June. In Argentina, local company Richmond Laboratories is manufacturing the vaccine, which will be used domestically and eventually exported to other countries in the region, according to Argentina’s health ministry

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

EU Pharma Reform: Exclusivity Vouchers Alone Are Insufficient Incentive For Antimicrobials, Industry Says

 
• By Eliza Slawther

European pharma trade associations EFPIA and EUCOPE outline their respective views on how the EU’s pharma legislation overhaul should tackle antimicrobial resistance, and why transferable exclusivity vouchers alone will not suffice as incentives.

What The EMA Can Teach HTA Bodies About Joint Clinical Assessments

 
• By Francesca Bruce

EU-level joint clinical assessments conducted under the Health Technology Assessment Regulation need to be more flexible when it comes to evidence requirements, according to experts speaking at a gene and cell therapy conference.

Switzerland Simplifies Imports Of Unauthorized Drugs To Tackle Drug Shortages

 
• By Eliza Slawther

Swiss authorities have introduced temporary measures that will make it easier for health care professionals to import medicines that are either not authorized or not available in Switzerland, which will particularly benefit pediatric drugs, in light of ongoing shortages.

EU ‘Can’t Expect Industry To Give Up Proprietary Insights’ Under Health Data & Clinical Trials Regulations

 
• By Eliza Slawther

Both the EU Clinical Trials Regulation and the European Health Data Space Regulation have the potential to improve harmonization and be highly valuable for industry – but the importance of protecting company data will be paramount, a life sciences consultant says.

More from Geography